Maternal-fetal cellular trafficking: Clinical implications and consequences

Current Opinion in Pediatrics

Volumn 26, Issue 3, 2014, Pages 377-382

  Jeanty, Cerine ^a   Derderian, S Christopher ^a   Mackenzie, Tippi C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fetal microchimerism; fetal surgery; maternal microchimerism; maternal fetal cellular trafficking

Indexed keywords

ANEUPLOIDY; AUTOIMMUNE DISEASE; CELL MIGRATION; CIRCULATION; FETOMATERNAL TRANSFUSION; FETUS CELL; FETUS CIRCULATION; FETUS SURGERY; GRAFT REJECTION; HUMAN; IMMUNOSURVEILLANCE; MATERNAL FETAL CELLULAR TRAFFICKING; MICROCHIMERISM; MOTHER FETUS RELATIONSHIP; NEOPLASM; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; TRANSPLANTATION; ADULT; AUTOIMMUNE DISEASES; CHIMERA; EMBRYOLOGY; FEMALE; FETAL THERAPY; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; NEWBORN; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS; PROCEDURES;

ADULT; ANEUPLOIDY; AUTOIMMUNE DISEASES; CHIMERISM; FEMALE; FETAL THERAPIES; GRAFT REJECTION; HISTOCOMPATIBILITY, MATERNAL-FETAL; HUMANS; IMMUNE TOLERANCE; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS;

EID: 84900460504     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000087     Document Type: Review

References (82)

1. Lapaire O, Holzgreve W, Oosterwijk JC, et al. Georg Schmorl on trophoblasts in the maternal circulation. Placenta 2007; 28:1-5
2. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996; 93:705-708
3. O'Donoghue K, Chan J, de la Fuente J, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 2004; 364:179-182
4. Koopmans M, Kreme r Hovinga IC, Baelde HJ, et al. Chimerism in kidneys, livers and hearts of normal women: implications for transplantation studies. Am J Transplant 2005; 5:1495-1502
5. Desai RG, Creger WP. Maternofetal passage of leukocytes and platelets in man. Blood 1963; 21:665-673
6. Maloney S, Smith A, Furst DE, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104:41-47
7. Ariga H, Ohto H, Busch MP, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal di agnosis. Transfusion 2001; 41:1524-1530
8. Lo YM, Lo ES, Watson N, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996; 88:4390-4395
9. Saadai P, Lee TH, Bautista G, et al. Alterations in maternal-fetal cellular trafficking after fetal surgery. J Pediatr Surg 2012; 47:1089-1094
10. Nijagal A, Wegorzewska M, Jarvis E, et al. Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice. J Clin Invest 2011; 121:582-592
11. Chen CP, Lee MY, Huang JP, et al. Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins. Stem Cells 2008; 26: 550-561
12. Holzgreve W, Ghezzi F, Di Naro E, et al. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998; 91:669-672
13. Bianchi DW, Farina A, Weber W, et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001; 184:703-706
14. Berry SM, H assan SS, Russell E, et al. Association of maternal histocompatibility at class II HLA loci with maternal microchimerism in the fetus. Pediatr Res 2004; 56:73-78
15. Lambert NC, Evans PC, Hashizumi TL, et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1-0501: implications in autoimmunity. J Immunol 2000; 164:5545-554 8
16. Roy E Leduc M Guegan S et al. Specific maternal microchimeric T cells targeting fetal antigens in beta cells predispose to auto-immune diabetes in the child. J Autoimmun 2011 36 253-2 62
17. Mold JE, Michaelsson J, Burt TD, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322:1562-1565
18. Khosrotehrani K, Guegan S, Fraitag S, et al. Presence of chimeric maternally derived keratinocytes in cutaneous inflammatory diseases of children: the example of pityriasis lichenoides. J Invest Dermatol 2006; 126:345-348
19. Khosrotehrani K, Johnson KL, Cha DH, et al. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004; 292:75-80
20. Stevens AM, Hermes HM, Rutledge JC, et al. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 2003; 362:1617-1623
21. Vanzyl B, Planas R, Ye Y, et al. Why are levels of maternal microchimerism higher in type 1 diabetes pancreas Chimerism 2010; 1:45-50
22. Cirello V, Perrino M, Colombo C, et al. Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissues. Int J Cancer 2010; 126:2874-2878
23. Gadi VK, Nelson JL. Fetal microchimerism in women with breast cancer. Cancer Res 2007; 67:9035-9038
24. Opiela SJ, Levy RB, Adkins B. Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens. Blood 2008; 112: 1530-1538
25. Dutta P, Molitor-Dart M, Bobadilla JL, et al. Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood 2009; 114:3578-3587
26. Rava RP, Srinivasan A, Sehnert AJ, Bianchi DW. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem 2014; 60:243-250
27. Farina A, Sekizawa A, Sugito Y, et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 2004; 24:83-86
28. Jakobsen TR, Clausen FB, Rode L, et al. High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery. Prenat Diagn 2012; 32:840-845
29. Hirayama M, Azuma E, Ito T, et al. A feasibility study on the prediction of acute graft-vs.-host disease before hematopoietic stem cell transplantation based on fetomaternal tolerance. Chimerism 2013; 4:84-86
30. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271
31. Erlebacher A, Vencato D , Price KA, et al. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 2007; 117:1399-1411
32. Nancy P, Tagliani E, Tay CS, et al. Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 2012; 336:1317-1321
33. Owen RD, Wood HR, Foord AG, et al. Evidence for actively acquired tolerance to Rh antigens. Proc Natl Acad Sci U S A 1954; 40:420-424
34. Farina A, LeShane ES, Romero R, et al. High levels of fetal cell-free DNA in maternal serum: a risk fa ctor for spontaneous preterm delivery. Am J Obstet Gynecol 2005; 193:421-425
35. Leung TN, Zhang J, Lau TK, et al. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998; 352:1904-1905
36. Al-Mufti R, Lees C, Albaiges G, et al. Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod 2000; 15: 218-221
37. Jakobsen TR Clausen FB Rode L et al. Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA. Transfusion 2013 53 1956-1964
38. Stein W, Muller S, Gutensohn K, et al. Cell-free fetal DNA and adverse outcome in low risk pregnancies. Eur J Obstet Gynecol Reprod Biol 2013; 166:10-13
39. Fleck S, Bautista G, K eating SM, et al. Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Res 2013; 74:290-298
40. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors. Prenat Diagn 2012; 32:1225-1232
41. Sirichotiyakul S, Charoenkwan P, Sanguansermsri T. Prenatal diagnosis of homozygous alpha-thalassemia-1 by cell-free fetal DNA in maternal plasma. Prenat Diagn 2012; 32:45-49
42. Wataganara T, Gratacos E, Jani J, et al. Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfus ion syndrome. Am J Obstet Gynecol 2005; 192:604-609
43. Tjoa ML, Jani J, Lewi L, et al. Circulating cell-free fetal messenger RNA levels after fetoscopic interventions of complicated pregnancies . Am J Obstet Gynecol 2006; 195:230-235
44. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364: 993-1004
45. Harrison MR, Keller RL, Hawgood SB, et al. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med 2003; 349:1916-1924
46. Senat MV, Deprest J, Boulvain M, et al. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004; 351:136-144
47. Wegorzewska M, Nijagal A, Wong CM, et al. Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immunemediated fetal demise. J Immunol 2014; 192:1938-1945
48. Khashan AS, Kenny LC, Laursen TM, et al. Pregnancy and the risk of autoimmune disease. PLoS One 2011; 6:e19658
49. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338:1186-1191
50. KlintscharM, Immel UD, Kehlen A, et al. Fetalmicrochimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol 2006; 154:237-241
51. Renne C, Ramos Lopez E, Steimle-Grauer SA, et al. Thyroid fetal male microchimerisms in mothers with thyroid di sorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves'disease than in follicular adenomas. J Clin Endocrinol Metab 2004; 89:5810-5814
52. Evans PC, Lambert N, Maloney S, et al. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999; 93:2033-2037
53. Scaletti C, Vultaggio A, Bonifacio S, et al. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002; 46:445-450
54. Khosrotehrani K, Leduc M, Bachy V, et al. Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J Immunol 2008; 180:889-897
55. Nguyen Huu S, Khosrotehrani K, Oster M, et al. Early phase of maternal skin carcinogenesis recruits long-term engrafted fetal cells. Int J Cancer 2008; 123:2512-2517
56. Zeng XX, Tan KH, Yeo A, et al. Pregnancy-associated progenitor cells differentiate and mature into neurons in the maternal brain. Stem Cells Dev 2010; 19:1819-1830
57. K hosrotehrani K, Reyes RR, Johnson KL, et al. Fetal cells participate over time in the response to specific types of murine maternal hepatic injury. Hum Reprod 2007; 22:654-661
58. Wang Y, Iw atani H, Ito T, et al. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 2004; 325:961-967
59. Sunami R Komuro M Yuminamo chi T et al. Fetal cell microchimerism develops through the migration of fetus-derived cells to the maternal organs early after implantation. J Reprod Immunol 2010 84 117-123
60. Seppanen E, Fisk NM, Khosrotehrani K. Pregnancy-acquired fetal progenitor cells. J Reprod Immunol 2013; 97:27-35
61. Nelson JL, Gillespie KM, Lambert NC, et al. Maternal microchimerism in peripheral b lood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A 2007; 104:1637-1642
62. Reed AM, Picornell YJ, Harwood A, Kredich DW. Chimerism in children with juvenile dermatomyositis. Lancet 2000; 356:2156-2157
63. Kobayashi H, Tamatani T, Tamura T, et al. Maternal microchimerism in biliary atresia. J Pediatr Surg 2007; 42:987-991; discussion 991
64. Kiefer AS, Lang TR, Hein MS, et al. Maternal microchimerism in Hirschsprung's disease. Am J Perinatol 2012; 29:71-78
65. Lopez-Guisa JM, Howsmon R, Munro A, et al. Chimeric maternal cells in offspring do not respond to renal injury, inflammatory or repair signals. Chimerism 2011; 2:42-49
66. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172:603-606
67. Vernochet C, Caucheteux SM, Gendron MC, et al. Affinity-dependent alterations of mouse B cell development by noninherited maternal antigen. Biol Reprod 2005; 72:460-469
68. Molitor-Dart ML, Andrassy J, Kwun J, et al. Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol 2007; 179:6749-6761
69. Stern M, Ruggeri L, Mancusi A, et al. Survival after T cell-depleted haploidentical stem cell transplantation is improv ed using the mother as donor. Blood 2008; 112:2990-2995
70. Nijagal A, Fleck S, Hills NK, et al. Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant 2012; 12:409-419
71. Burlingham WJ, Grailer A P, Heisey DM, et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998; 339:1657-1664
72. van Rood JJ, Lob eriza FR Jr., Zhang MJ, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002; 99: 1572-1577
73. Opelz G. Analysis of the 'NIMA effect'in renal transplantation. Collaborative Transplant Study. Clin Transpl 1990; 4:63-67
74. Panajotopoulos N, Ianhez LE, Neumann J, et al. Immunological tolerance in human transplantation. The possible existence of a maternal effect. Transplantation 1990; 50:443-445
75. Okumura H, Yamaguchi M, Kotani T, et al. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from noninherited maternal-antigen-complementary HLA-mismatched siblings. Eur J Haematol 2007; 78:157-160
76. Muller SM, Ege M, Pottharst A, et al. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 2001; 98:1847-1851
77. Araki M, Hirayama M, Azuma E, et al. Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigenmatched stem cell transplantation in a mouse model. J Immunol 2010; 185:7739-7745
78. Gadi VK. Fetal microchimerism in breast from women with and without breast cancer. Breast Cancer Res Treat 2010; 121:241-244
79. O'Donoghue K, Sultan HA, Al-Allaf FA, et al. Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. Reprod Biomed Online 2008; 16:382-390
80. Dubernard G Aractingi S Oster M et al. Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res 2008 10 R14
81. Cha D, Khosrotehrani K, Kim Y, et al. Cervical cancer and microchimerism. Obstet Gynecol 2003; 102:774-781
82. Nguyen Huu S,Oster M, Avril MF, et al. Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol 2009; 174:630-637.